These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. High concentrations of plasma brain-derived neurotrophic factor in methamphetamine users. Kim DJ; Roh S; Kim Y; Yoon SJ; Lee HK; Han CS; Kim YK Neurosci Lett; 2005 Nov; 388(2):112-5. PubMed ID: 16039058 [TBL] [Abstract][Full Text] [Related]
23. 'Ice epidemic'? Trends in methamphetamine use from three Victorian surveillance systems. Lim MS; Cogger S; Quinn B; Hellard ME; Dietze PM Aust N Z J Public Health; 2015 Apr; 39(2):194-5. PubMed ID: 25559677 [No Abstract] [Full Text] [Related]
24. Why do we need an Addiction supplement focused on methamphetamine? Rawson RA; Condon TP Addiction; 2007 Apr; 102 Suppl 1():1-4. PubMed ID: 17493048 [TBL] [Abstract][Full Text] [Related]
25. Crystallizing the HIV epidemic: methamphetamine, unsafe sex, and gay diseases of the will. Worth H; Rawstorne P Arch Sex Behav; 2005 Oct; 34(5):483-6. PubMed ID: 16211470 [No Abstract] [Full Text] [Related]
28. A complicated case of bowel obstruction with sepsis and methamphetamine toxicity in a child with pica. Stevens C; Ton E; Jones P; Shattuck B Forensic Sci Med Pathol; 2019 Dec; 15(4):598-602. PubMed ID: 31444700 [TBL] [Abstract][Full Text] [Related]
29. Methamphetamine abuse: medical and dental considerations. Smart RJ; Rosenberg M J Mass Dent Soc; 2005; 54(2):44-6, 48-9. PubMed ID: 16149403 [TBL] [Abstract][Full Text] [Related]
30. Major physical and psychological harms of methamphetamine use. Darke S; Kaye S; McKetin R; Duflou J Drug Alcohol Rev; 2008 May; 27(3):253-62. PubMed ID: 18368606 [TBL] [Abstract][Full Text] [Related]
31. Clinical effects and management of methamphetamine abuse. Romanelli F; Smith KM Pharmacotherapy; 2006 Aug; 26(8):1148-56. PubMed ID: 16863490 [TBL] [Abstract][Full Text] [Related]
32. Meth: What You Should Know. Am Fam Physician; 2018 Jul; 98(2):Online. PubMed ID: 30216002 [No Abstract] [Full Text] [Related]
33. Clinical and Autopsy Characteristics of Fatal Methamphetamine Toxicity in Australia. Darke S; Duflou J; Lappin J; Kaye S J Forensic Sci; 2018 Sep; 63(5):1466-1471. PubMed ID: 29193063 [TBL] [Abstract][Full Text] [Related]
34. Commentary on Marshall et al. (2010): are long-term negative health consequences of methamphetamine use important to youth? Rawson RA; Gonzales R Addiction; 2010 Jun; 105(6):1003-4. PubMed ID: 20659060 [No Abstract] [Full Text] [Related]
35. Triple trouble: cognitive deficits from hepatitis C, HIV, and methamphetamine. van Gorp WG; Hinkin CH Neurology; 2005 Apr; 64(8):1328-9. PubMed ID: 15851716 [No Abstract] [Full Text] [Related]
36. Methamphetamine and cardiovascular pathology: a review of the evidence. Kaye S; McKetin R; Duflou J; Darke S Addiction; 2007 Aug; 102(8):1204-11. PubMed ID: 17565561 [TBL] [Abstract][Full Text] [Related]
38. Opioids and methamphetamine: a tale of two crises. The Lancet Lancet; 2018 Feb; 391(10122):713. PubMed ID: 29486928 [No Abstract] [Full Text] [Related]
39. The burden and management of crystal meth use. Buxton JA; Dove NA CMAJ; 2008 Jun; 178(12):1537-9. PubMed ID: 18519899 [No Abstract] [Full Text] [Related]
40. Behavioral health issue brief: treatment of methamphetamine abuse: year end report-2002. Colker AC Issue Brief Health Policy Track Serv; 2002 Dec; ():1-8. PubMed ID: 12875274 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]